LONSURF
LIVE

Serial Number

79183501

Owner

TAIHO PHARMACEUTICAL CO., LTD.

Attorney

Dionne D. Heard

Filing Date

Oct 22, 2015

Add to watchlist:

No watchlists yet
View on USPTO

LONSURF Trademark

Serial Number: 79183501 • Registration: 5121586

LONSURF is a trademark filed by TAIHO PHARMACEUTICAL CO., LTD. on October 22, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

TAIHO PHARMACEUTICAL CO., LTD. (107 trademarks)

CHIYODA-KU, TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

October 22, 2015

Registration Date

January 17, 2017

Published for Opposition

November 1, 2016

Goods & Services

[ Scientific research for medical purposes in the field of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; testing, inspection, research or evaluation of pharmaceuticals; advisory, consultancy or information services relating to testing, inspection, research or evaluation of pharmaceuticals and medicines; testing, inspection, research or evaluation of medicine, pharmaceutical preparations, and clinical medical trials; advisory, consultancy or information services relating to testing, inspection, research or evaluation of medicine, pharmaceutical preparations, and clinical medical trials; medical and scientific research, namely, conducting clinical trials for medicine; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; design and development of computer hardware and software for use in the field of medicine; research and development of medical technology; providing information about medical and scientific research in the field of pharmaceuticals; scientific research for medical purposes in the area of cancerous diseases; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; computer programming for the medical sector ]

Medical diagnostic testing in the fields of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing medical information relating to the treatment or prevention of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical consultation services relating to the treatment and diagnosis of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical counseling services relating to the treatment of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; genetic testing for medical purposes, namely, for the diagnosis and prognosis of the expected progression of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing medical information relating to the efficacy, side effects, and interactions of pharmaceuticals and medications; medical services; providing medical information; physical examination; [ dentistry; ] preparation and dispensing of medications; medical analysis services for the diagnosis of cancer; medical information services provided via the Internet; providing medical information, consultancy and advisory services; providing information to patients in the field of administering medication; dietetic advisory services; health care services for treating cancer

Pharmaceutical preparations, namely, anti-cancer agents, anti-tumor agents [, anti-ulcerogenic agents, agents for treatment of immunological diseases, agents for the treatment of urinary diseases, agents for pain, antiemetic agents; diagnostic agents, preparations and substances for medical purposes; preparations for detecting genetic predispositions for medical purposes; chemical reagents for medical or veterinary purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; capsules sold empty for pharmaceuticals; eyepatches for medical use; ear bandages; menstruation bandages; sanitary tampons; sanitary napkins; sanitary panties; cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; antiseptic liquid bandages; breast-nursing pads; dental adhesives; dental amalgams; dental cements; dental ceramics; dental polish; dental veneers; material for dental fillings and dental impressions; dental composite materials; dental impression materials; dental restoration compounds; sealing agents for dental purposes; lacteal flour for babies; dietary supplements for humans; dietetic foods, namely, biscuit, jelly, soup adapted for medical use; beverages for babies; food for babies ]

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jan 17, 2026 REM4
INTERNATIONAL REGISTRATION RENEWED
Sep 25, 2025 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Mar 21, 2025 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Dec 21, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 22, 2024 INPS
INVALIDATION PROCESSED
Nov 22, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 5, 2024 INPR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 16, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 16, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 16, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 16, 2024 REAP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Mar 4, 2024 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Mar 4, 2024 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 26, 2024 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 9, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 9, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 9, 2024 REAP
TEAS SECTION 71 & 15 RECEIVED
Jun 15, 2023 ES75
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 26, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 26, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 26, 2023 REAP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 17, 2022 REM3
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 27, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 27, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 27, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 27, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 27, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 27, 2021 COAR
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Nov 1, 2019 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 11, 2019 INPR
CORRECTION UNDER SECTION 7 - PROCESSED
Jan 28, 2019 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 24, 2019 APRE
TEAS SECTION 7 REQUEST RECEIVED
Dec 14, 2018 ES7R
CORRECTION UNDER SECTION 7 - PROCESSED
May 15, 2018 COC.
FINAL DECISION TRANSACTION PROCESSED BY IB
May 13, 2017 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Apr 21, 2017 FICS
FINAL DISPOSITION PROCESSED
Apr 21, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 17, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 17, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 12, 2016 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Sep 26, 2016 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 23, 2016 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 16, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 16, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 16, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 16, 2016 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 31, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 31, 2016 REAP
REFUSAL PROCESSED BY IB
May 13, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 18, 2016 RFCS
REFUSAL PROCESSED BY MPU
Mar 18, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2016 RFCR
NON-FINAL ACTION WRITTEN
Mar 17, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 4, 2016 MAFR
ASSIGNED TO EXAMINER
Feb 29, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 29, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 26, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 25, 2016 REPR